MarketScreener Homepage > Equities > Swiss Exchange > Santhera Pharmaceuticals Holding AG SANN CH0027148649

Report

Delayed Swiss Exchange - 01/27 08:17:31 am
2.98	CHF		-1.32%

2020

SANTHERA PHARMACEUTICALS : Completes Capital Increase for Financing Arrangements

2020

2020

SANTHERA PHARMACEUTICALS : Completes Capital Increase for Financing Arrangements

Upcoming events on SANTHERA PHARMACEUTICALS HOLDING AG

06/22/21

Annual General Meeting

Past events on SANTHERA PHARMACEUTICALS HOLDING AG

01/06/21		LifeSci Advisors Corporate Access Event
11/17/20 \| 06:10am		Jefferies Healthcare Conference
10/06/20 \| 07:00am		Business Update Call
09/14/20		H.C. Wainwright & Co., LLC Global Investment Conference

Upcoming sector events for SANTHERA PHARMACEUTICALS HOLDING AG

01/28/21		AMGEN INC. : International Association for the Study of Lung Cancer World Conference - Abstract No - #P15.01
01/28/21		SUMITOMO DAINIPPON PHARMA CO., LTD. : Q3 2020 Präsentation des Ergebnisses
01/28/21		ASTRAZENECA PLC : International Association for the Study of Lung Cancer World Conference - Abstract #FP76.72
01/28/21		ASTRAZENECA PLC : International Association for the Study of Lung Cancer World Conference - Abstract #FP14.03

Past sector events for SANTHERA PHARMACEUTICALS HOLDING AG

01/26/21 \| 02:30pm		JOHNSON & JOHNSON : Jahr 2020 Präsentation des Ergebnisses
01/26/21 \| 02:00pm		NOVARTIS AG : Jahr 2020 Präsentation des Ergebnisses
01/26/21 \| 12:45pm		JOHNSON & JOHNSON : Jahr 2020 Ergebnisveröffentlichung
01/26/21		NOVARTIS AG : Jahr 2020 Ergebnisveröffentlichung

Annual publications

Annual results		2015	2016	2017	2018	2019	2020 (e)
Sales M CHF	Released Forecast Spread	4,30 6,80 -37%	19,0 19,0 0,17%	22,9 22,6 1,4%	31,7 31,4 0,98%	75,4 76,1 -0,95%	14,6
Operating income (EBITDA) M CHF	Released Forecast Spread	-22,8 -21,0 -8,6%	-29,9 -25,5 -17%	-47,1 -48,8 3,5%	-47,7 -50,1 4,8%	-5,67 -1,92 -195%	-37,4
Operating profit (EBIT) M CHF	Released Forecast Spread	-23,9 -21,1 -13%	-33,1 -32,2 -2,9%	-50,5 -45,7 -10%	-51,4 -54,4 5,5%	-10,4 -5,30 -97%	-46,7
Pre-Tax Profit (EBT) M CHF	Released Forecast Spread		-33,2 -32,0 -3,8%	-51,3 -47,1 -8,9%	-53,9 -53,4 -0,81%	-18,4 0,41 -4 597%	-54,0
Net income M CHF	Released Forecast Spread	5,95 -21,0 128%	-35,4 -28,6 -24%	-51,5 -47,1 -9,4%	-54,2 -54,4 0,45%	-19,0 0,41 -4 739%	-55,3
EPS CHF	Released Forecast Spread	1,08 -4,22 126%	-5,65 -4,68 -21%	-8,22 -6,53 -26%	-7,86 -7,85 -0,19%	-1,73 0,04 -4 776%	-3,17
Announcement Date		04/12/2016	03/07/2017	03/20/2018	04/29/2019	03/24/2020

Quarterly publications

Previous period

Next period

Quarterly results		2015 S2	2016 S1	2016 S2	2017 S1	2017 S2
Sales M CHF	Released Forecast Spread	2,85 5,30 -46%	7,21 7,00 3,0%	11,8 11,8 0,19%	10,9 11,1 -2,2%	12,1 11,2 7,9%
Operating income (EBITDA) M CHF	Released Forecast Spread	-17,9 -15,0 -19%	-17,2 -9,10 -89%	-15,9 -15,8 -0,59%	-21,4 -6,30 -239%	-29,1 -14,6 -99%
Operating profit (EBIT) M CHF	Released Forecast Spread			-16,1 -15,8 -1,7%	-22,7 -6,30 -260%	-28,6 -14,6 -96%
Pre-Tax Profit (EBT) M CHF	Released Forecast Spread			-17,4 -15,8 -10%	-22,7 -5,80 -292%	-28,8 -14,6 -97%
Net income	Released Forecast Spread		-2,87 -1,42 -102%	-2,78 -2,51 -11%	-3,62 -0,91 -298%	-4,60 -2,30 -100%
Announcement Date		04/12/2016	09/06/2016	03/07/2017	09/05/2017	03/20/2018

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise